SFA THERAPEUTICS Trademark

Trademark Overview


On Tuesday, April 5, 2022, a trademark application was filed for SFA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SFA THERAPEUTICS trademark a serial number of 97348334. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by SFA Therapeutics, Inc.. The SFA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific research for medical purposes in the fields of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; research and development of pharmaceuticals for the treatment of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials

Pharmaceutical preparations for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; pharmaceutical products for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases
sfa therapeutics

General Information


Serial Number97348334
Word MarkSFA THERAPEUTICS
Filing DateTuesday, April 5, 2022
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7165936
Registration DateTuesday, September 12, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesScientific research for medical purposes in the fields of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; research and development of pharmaceuticals for the treatment of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials
Goods and ServicesPharmaceutical preparations for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; pharmaceutical products for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 26, 2023
Primary Code005
First Use Anywhere DateSunday, May 10, 2020
First Use In Commerce DateSunday, May 10, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code042
First Use Anywhere DateFriday, April 22, 2022
First Use In Commerce DateFriday, April 22, 2022

Trademark Owner History


Party NameSFA Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJenkintown, PA 19046

Party NameSFA Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJenkintown, PA 19046

Party NameSFA Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJenkintown, PA 19046

Trademark Events


Event DateEvent Description
Friday, April 8, 2022NEW APPLICATION ENTERED
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 21, 2023ASSIGNED TO EXAMINER
Thursday, January 26, 2023NON-FINAL ACTION WRITTEN
Thursday, January 26, 2023NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, January 26, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, January 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 26, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, January 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 28, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, July 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 28, 2023USE AMENDMENT FILED
Saturday, July 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 5, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, November 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, November 10, 2025WITHDRAWAL OF ATTORNEY GRANTED